title: [Benign prostatic hyperplasia--treatment with sabal fruit extract. A treatment study of 1,334 patients].
abstract: METHODS
  In a drug monitoring study, 1,334 outpatients with benign prostatic hyperplasia (BPH) were treated for 12 weeks with an extract from the fruits of Sabal serrulata.
  
  
  RESULTS
  Under this treatment, the volume of residual urine decreased by 50%, pollakisuria decreased on average by 37%, and nocturia by 54%. The percentage of patients with dysuric pain decreased from 75% to 37%. The efficacy of the drug was rated good to excellent in more than 80% of the cases, and good to excellent tolerability was reported by more than 95% of the patients.
  
  
  CONCLUSIONS
  The improvement in the irritative symptoms may be considered relevant in terms of improvement in the quality of the life of the patients, and justifies this form of treatment.
authors.affiliation: Urologische Klinik und Poliklinik, Klinikum Grosshadern der Universität München.
authors.forename: W
authors.initials: W
authors.lastname: Vahlensieck
authors.forename: A
authors.initials: A
authors.lastname: Völp
authors.forename: W
authors.initials: W
authors.lastname: Lubos
authors.forename: M
authors.initials: M
authors.lastname: Kuntze
mesh_terms: D058891:5-alpha Reductase Inhibitors; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016903:Drug Monitoring; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000008:administration & dosage* / Q000009:adverse effects; D011470:Prostatic Hyperplasia / Q000628:therapy*; D014563:Urodynamics / Q000187:drug effects
chemical_list: D058891:5-alpha Reductase Inhibitors; D010936:Plant Extracts